Novartis Investigative Site

Maastricht, AZ 6202

0 studies enrolling now · 6 studies all time

What they study most

Atherosclerosis, Breast Cancer, Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD), Hemodialysis, Hormone Receptor Positive Breast Cancer, Metastatic Breast Cancer, Parkinson's Disease Dementia, Renal Replacement Therapy, Renal Transplantation

Studies at this site

• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi — Stopped early
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) — Completed
• Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) — Completed